These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 37493490)
1. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis. Magnocavallo M; Vetta G; Polselli M; Cauti FM; Parlavecchio A; Caminiti R; Crea P; Pannone L; Sorgente A; Chimenti C; Chierchia GB; Rossi P; Natale A; de Asmundis C; Bianchi S; Della Rocca DG J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1781-1784. PubMed ID: 37493490 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of late-gadolinium enhancement on cardiac magnetic resonance in patients with cardiac sarcoidosis. Al-Sadawi M; Henriques M; Tao M; Gier C; Kim P; Aslam F; Almasry I; Singh A; Fan R; Rashba E Pacing Clin Electrophysiol; 2023 Jul; 46(7):657-664. PubMed ID: 37216284 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis. Stevenson A; Bray JJH; Tregidgo L; Ahmad M; Sharma A; Ng A; Siddiqui A; Khalid AA; Hylton K; Ionescu A; Providencia R; Kirresh A JACC Cardiovasc Imaging; 2023 Mar; 16(3):345-357. PubMed ID: 36752432 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of RV Abnormalities on CMR in Patients With Known or Suspected Cardiac Sarcoidosis. Wang J; Zhang J; Hosadurg N; Iwanaga Y; Chen Y; Liu W; Wan K; Patel AR; Wicks EC; Gkoutos GV; Han Y; Chen Y JACC Cardiovasc Imaging; 2023 Mar; 16(3):361-372. PubMed ID: 36752447 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis. Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165 [TBL] [Abstract][Full Text] [Related]
6. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis. Velangi PS; Chen KA; Kazmirczak F; Okasha O; von Wald L; Roukoz H; Farzaneh-Far A; Markowitz J; Nijjar PS; Bhargava M; Perlman D; Akçakaya M; Shenoy C JACC Cardiovasc Imaging; 2020 Jun; 13(6):1395-1405. PubMed ID: 31954639 [TBL] [Abstract][Full Text] [Related]
7. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis. Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357 [TBL] [Abstract][Full Text] [Related]
8. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675 [TBL] [Abstract][Full Text] [Related]
9. Spatial dispersion analysis of LGE-CMR for prediction of ventricular arrhythmias in patients with cardiac sarcoidosis. Aronis KN; Okada DR; Xie E; Daimee UA; Prakosa A; Gilotra NA; Wu KC; Trayanova N; Chrispin J Pacing Clin Electrophysiol; 2021 Dec; 44(12):2067-2074. PubMed ID: 34766627 [TBL] [Abstract][Full Text] [Related]
10. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Kuruvilla S; Adenaw N; Katwal AB; Lipinski MJ; Kramer CM; Salerno M Circ Cardiovasc Imaging; 2014 Mar; 7(2):250-258. PubMed ID: 24363358 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494 [TBL] [Abstract][Full Text] [Related]
12. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy. Ota S; Orii M; Nishiguchi T; Yokoyama M; Matsushita R; Takemoto K; Tanimoto T; Hirata K; Hozumi T; Akasaka T J Cardiovasc Magn Reson; 2021 Mar; 23(1):32. PubMed ID: 33761955 [TBL] [Abstract][Full Text] [Related]
13. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy. Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820 [TBL] [Abstract][Full Text] [Related]
14. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. Disertori M; Rigoni M; Pace N; Casolo G; Masè M; Gonzini L; Lucci D; Nollo G; Ravelli F JACC Cardiovasc Imaging; 2016 Sep; 9(9):1046-1055. PubMed ID: 27450871 [TBL] [Abstract][Full Text] [Related]
15. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis. Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421 [TBL] [Abstract][Full Text] [Related]
16. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. Di Marco A; Anguera I; Schmitt M; Klem I; Neilan TG; White JA; Sramko M; Masci PG; Barison A; Mckenna P; Mordi I; Haugaa KH; Leyva F; Rodriguez Capitán J; Satoh H; Nabeta T; Dallaglio PD; Campbell NG; Sabaté X; Cequier Á JACC Heart Fail; 2017 Jan; 5(1):28-38. PubMed ID: 28017348 [TBL] [Abstract][Full Text] [Related]
17. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis. Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203 [TBL] [Abstract][Full Text] [Related]
18. The role of late gadolinium enhancement in predicting arrhythmic events in cardiac sarcoidosis patients - a mini-review. Bazoukis G; Liatakis I; Vassiliou VS; Tse G; Gounopoulos P; Saplaouras A; Letsas KP; Vlachos K; Papadatos SS; Konstantinidou E; Lakoumentas I; Sideris A; Efremidis M Acta Cardiol; 2022 Nov; 77(9):768-773. PubMed ID: 35086421 [TBL] [Abstract][Full Text] [Related]
19. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822 [TBL] [Abstract][Full Text] [Related]
20. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Scott PA; Rosengarten JA; Curzen NP; Morgan JM Eur J Heart Fail; 2013 Sep; 15(9):1019-27. PubMed ID: 23558217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]